Isolated Limb Infusion: A Single-Center Experience with Over 200 Infusions-Reference-Cited by-同舟云学术

Isolated Limb Infusion: A Single-Center Experience with Over 200 Infusions

Published:2017-10-10 Issue:13 Volume:24 Page:3842-3849
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

O’Donoghue Cristina,Perez Matthew C.,Mullinax John E.,Hardman Danielle,Sileno Sean,Naqvi Syeda Mahrukh Hussnain,Kim Youngchul,Gonzalez Ricardo J.,Zager Jonathan S.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/article/10.1245/s10434-017-6107-9/fulltext.html

Reference21 articles.

1. Specenier P. Pembrolizumab use for the treatment of advanced melanoma. Expert Opin Biol Ther. 2017;17(6):765–80.

2. Mullinax JE, Kroon HM, Thompson JF, et al. Isolated limb infusion as a limb salvage strategy for locally advanced extremity sarcoma. J Am Coll Surg. 2017;224(4):635–42.

3. Thompson JF, Kam PC, Waugh RC, Harman CR. Isolated limb infusion with cytotoxic agents: a simple alternative to isolated limb perfusion. Semin Surg Oncol. 1998;14(3):238–47.

4. Thompson JF, Hunt JA, Shannon KF, Kam PC. Frequency and duration of remission after isolated limb perfusion for melanoma. Arch Surg. 1997;132(8):903–7.

5. Sanki A, Kam PC, Thompson JF. Long-term results of hyperthermic, isolated limb perfusion for melanoma: a reflection of tumor biology. Ann Surg. 2007;245(4):591–6.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isolated Limb Infusion for Limb-Threatening Sarcomas;Annals of Surgical Oncology;2024-09-10

2. Treatment for Regionally Advanced and In-transit Melanoma;Melanoma;2024

3. The Diagnosis and Management of Cutaneous Metastases from Melanoma;International Journal of Molecular Sciences;2023-09-26

4. Isolated Limb Infusion for Limb-Threatening, Unresectable Sarcoma: Past Progress, Current Applications, and Future Directions;Journal of Clinical Medicine;2023-06-13

5. Management of In-Transit Metastatic Melanoma;Advances in Oncology;2023-05